Temozolomide,Toripalimab
Coherus,Junshi Biosciences
['melanoma']
#melanomaorals #asco23 a retrospective study from china that showed a potential better benefit for adjuvant chemo when compared to pd1-i for resected mucosal melanoma, especially for pd-l1 neg patients. maybe worth investigating in a prospective study 
Medical Oncology fellow at Duke University, Lebanese, husband to the best anesthesiologist, father, IO fan, trialist and skin cancer specialist to be!